Advances and transgressions of nuclear transport checkpoint inhibitors.
作者信息
Hawiger Jacek
机构信息
Vanderbilt University School of Medicine, Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Nashville, TN, USA; Vanderbilt University School of Medicine, Department of Molecular Physiology and Biophysics, Nashville, TN, USA; Department of Veterans Affairs, Tennessee Valley Health Care System, Nashville, TN, USA.
出版信息
Mol Ther. 2024 May 1;32(5):1181-1184. doi: 10.1016/j.ymthe.2024.03.021. Epub 2024 Apr 4.
Abstract
摘要
相似文献
1
Advances and transgressions of nuclear transport checkpoint inhibitors.
Mol Ther. 2024 May 1;32(5):1181-1184. doi: 10.1016/j.ymthe.2024.03.021. Epub 2024 Apr 4.
2
Immune Checkpoint Molecules: A Review on Pathways and Immunotherapy Implications.
Immun Inflamm Dis. 2025 Apr;13(4):e70196. doi: 10.1002/iid3.70196.
3
Immune checkpoint inhibitors and immunosuppressive tumor microenvironment: current challenges and strategies to overcome resistance.
Immunopharmacol Immunotoxicol. 2025 Aug;47(4):485-507. doi: 10.1080/08923973.2025.2504906. Epub 2025 Jun 5.
4
Editorial: Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer.
Front Immunol. 2021 Oct 21;12:781872. doi: 10.3389/fimmu.2021.781872. eCollection 2021.
5
Patients' experiences of cancer immunotherapy with immune checkpoint inhibitors: A systematic review and thematic synthesis.
J Clin Nurs. 2024 Aug;33(8):2885-2904. doi: 10.1111/jocn.17154. Epub 2024 Apr 8.
6
TAM kinase inhibition and immune checkpoint blockade- a winning combination in cancer treatment?
Expert Opin Ther Targets. 2021 Feb;25(2):141-151. doi: 10.1080/14728222.2021.1869212. Epub 2020 Dec 31.
7
Targeting the tumor microenvironment to overcome immune checkpoint blockade therapy resistance.
Immunol Lett. 2020 Apr;220:88-96. doi: 10.1016/j.imlet.2019.03.006. Epub 2019 Mar 15.
8
Rationale of using immune checkpoint inhibitors (ICIs) and anti-angiogenic agents in cancer treatment from a molecular perspective.
Clin Exp Med. 2025 Jul 8;25(1):238. doi: 10.1007/s10238-025-01751-7.
9
Boosting cancer immunotherapy: drug delivery systems leveraging ferroptosis and immune checkpoint blockade.
Front Immunol. 2025 Jun 25;16:1611299. doi: 10.3389/fimmu.2025.1611299. eCollection 2025.
10
Adding immune checkpoint inhibitors to chemotherapy in elderly cancer patients: Beneficial for many but not all?
Tumori. 2025 Aug;111(4):284-292. doi: 10.1177/03008916251328539. Epub 2025 Jun 6.
本文引用的文献
1
Cytoplasmic retention of the DNA/RNA-binding protein FUS ameliorates organ fibrosis in mice.
J Clin Invest. 2024 Mar 15;134(6):e175158. doi: 10.1172/JCI175158.
2
Intracellular delivery of nuclear localization sequence peptide mitigates COVID-19 by inhibiting nuclear transport of inflammation-associated transcription factors.
Mol Ther. 2024 Jan 3;32(1):227-240. doi: 10.1016/j.ymthe.2023.11.002. Epub 2023 Nov 4.
3
Activation of thousands of genes in the lungs and kidneys by sepsis is countered by the selective nuclear blockade.
Front Immunol. 2023 Aug 11;14:1221102. doi: 10.3389/fimmu.2023.1221102. eCollection 2023.
4
Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers.
Sci Transl Med. 2023 Aug 2;15(707):eadf7006. doi: 10.1126/scitranslmed.adf7006.
5
Genomic control of inflammation in experimental atopic dermatitis.
Sci Rep. 2022 Nov 7;12(1):18891. doi: 10.1038/s41598-022-23042-x.
6
Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19.
JAMA Netw Open. 2021 Dec 1;4(12):e2140568. doi: 10.1001/jamanetworkopen.2021.40568.
7
Hyperlipidemic hypersensitivity to lethal microbial inflammation and its reversal by selective targeting of nuclear transport shuttles.
Sci Rep. 2021 Jun 7;11(1):11907. doi: 10.1038/s41598-021-91395-w.
8
The spatial landscape of lung pathology during COVID-19 progression.
Nature. 2021 May;593(7860):564-569. doi: 10.1038/s41586-021-03475-6. Epub 2021 Mar 29.
9
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4570. Epub 2020 Sep 24.
10
EGF receptor-mediated FUS phosphorylation promotes its nuclear translocation and fibrotic signaling.
J Cell Biol. 2020 Sep 7;219(9). doi: 10.1083/jcb.202001120.
Zotero 插件